10-KPeriod: FY2015

CVS HEALTH Corp Annual Report, Year Ended Dec 31, 2015

Filed February 9, 2016For Securities:CVS

Summary

CVS Health Corporation's 2015 10-K filing highlights a robust, integrated healthcare model aiming to improve health outcomes and manage costs. The company operates across three main segments: Pharmacy Services (encompassing its PBM business, CVS Caremark), Retail/LTC (including its extensive retail pharmacy chain, MinuteClinics, and long-term care pharmacies), and Corporate. A key strategic focus is leveraging its integrated capabilities, such as combining retail pharmacy presence with PBM services, to offer unique solutions to consumers, payors, and providers. Significant strategic moves in 2015 included the acquisitions of Omnicare and Target's pharmacy and clinic businesses, expanding its reach in long-term care and retail presence, respectively. The company emphasizes innovation in its service offerings, from patient counseling and medication adherence programs to advanced digital tools for customer engagement. Despite operating in a highly competitive and regulated environment, CVS Health demonstrates a commitment to growth through strategic acquisitions and organic expansion of its store and clinic footprint, alongside a focus on operational efficiency and leveraging its vast network to drive value.

Financial Highlights

58 data points
Beta

Revenue

$153.29B

17.3% Gross Margin

Net Income

$5.24B

3.4% Net Margin

EPS (Diluted)

$4.63

Total Assets

$92.44B

Cash & Equivalents

$2.46B

Free Cash Flow

$6.17B

Financial Statements
Beta
Revenue$153.29B
Cost of Revenue$126.76B
Gross Profit$26.53B
Operating Expenses$17.05B
Operating Income$9.47B
Interest Expense$859.00M
Net Income$5.24B
EPS (Basic)$4.66
EPS (Diluted)$4.63
Shares Outstanding (Basic)1.12B
Shares Outstanding (Diluted)1.13B

Key Highlights

  • 1CVS Health operates an integrated pharmacy healthcare model with three reportable segments: Pharmacy Services, Retail/LTC, and Corporate.
  • 2The company made significant strategic acquisitions in 2015, including Omnicare (long-term care pharmacy) and Target's pharmacy and clinic businesses.
  • 3CVS Health's Pharmacy Services segment managed approximately 1 billion prescriptions in 2015, offering a full range of PBM solutions.
  • 4The Retail/LTC segment includes approximately 9,600 retail pharmacies, over 1,100 walk-in medical clinics (MinuteClinic), and expanded long-term care operations.
  • 5The company emphasizes leveraging its integrated model and digital tools to enhance customer engagement, improve health outcomes, and lower healthcare costs.
  • 6CVS Health reported net revenues of $153.3 billion and net income attributable to CVS Health of $5.24 billion for the year ended December 31, 2015.
  • 7The company actively engaged in share repurchases, with approximately $7.7 billion available for future repurchases under its 2014 Repurchase Program as of year-end 2015.

Frequently Asked Questions

In 2015, CVS Health significantly expanded its operations through two key acquisitions: Omnicare, which broadened its base into long-term care pharmacy services, and the pharmacy and clinic businesses of Target, which expanded its retail pharmacy and clinic footprint, particularly in new and existing markets.

CVS Health differentiates itself through its integrated pharmacy healthcare model, being the only company with the ability to impact consumers, payors, and providers with channel-agnostic solutions. This integration allows for innovative approaches to managing costs and care, leveraging its extensive retail pharmacy network, PBM services (CVS Caremark), and walk-in clinics (MinuteClinic).

The company's strategy involves continued growth through strategic acquisitions and organic expansion of its retail stores and clinics, alongside a focus on operational efficiency. It aims to enhance customer engagement through digital tools and personalized services, improve health outcomes via clinical programs, and leverage its integrated capabilities to manage healthcare costs effectively.

CVS Health operates in a highly competitive and regulated industry. Key risks include declining gross margins in PBM and pharmacy sectors due to pricing pressures, efforts to reduce reimbursement levels by payors, the need for continuous compliance with a complex regulatory framework, and potential disruptions to information technology systems. Additionally, the company faces risks related to market availability of drugs and potential changes in healthcare reform.